Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biophile is a microbiome-focused biotechnology company that develops high-performance skincare products based on bio-fermentation and microbial science. The company's core technology, the Biotic Broth, is a proprietary complex of probiotic lysates, prebiotic sugars, and postbiotic metabolites designed to support and balance the skin's natural ecosystem. By leveraging advanced fermentation processes, Biophile creates bioactive formulations that address skin health, aging, and inflammation without the use of traditional preservatives that can disrupt the microbiome. The company positions itself at the intersection of clean beauty and clinical biotech, offering a range of serums and essences that are biologically active and sustainable.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biophile.